Two-thirds of adults in the United States have received or intend to receive an influenza vaccination this flu season.
Study authors evaluated influenza-vaccinated patients hospitalized with an influenza-like illness to identify characteristics associated with being at increased risk for hospitalization with influenza.
Investigators used precision surveillance by combining genomic sequencing and conventional surveillance to delineate a nosocomial viral outbreak; they believe the findings of their study are applicable to a range of respiratory pathogens, including SARS-CoV-2.
In the peramivir arm, the median time to alleviation of combined influenza symptoms was 79 hours compared with 100 hours in the oseltamivir arm.
Both trivalent adjuvanted inactivated influenza vaccine or the trivalent high-dose inactivated influenza vaccine is safe to use in older adults.
Study authors evaluated the performance of symptom-based definitions to detect influenza in a cohort of pregnant women in India, Peru, and Thailand.
Researchers investigated the effects of ILI on pneumococcal carriage in community-dwelling older adults.
Investigators quantified the risk of antenatal influenza and examined its association with perinatal outcomes.